NCT04062214

Brief Summary

Veterans seeking compensation for musculoskeletal (MSD) conditions often develop chronic pain and are at high risk for substance misuse. The Investigators propose to test the effectiveness and cost-effectiveness of Screening, Brief Intervention and Referral to Treatment for Pain Management (SBIRT-PM), designed to reduce pain and reduce risky substance use, in part by helping Veterans get comprehensive pain treatment. The study will involve clinicians at a single site contacting Veterans throughout New England by phone to deliver SBIRT-PM counseling in a pragmatic, randomized, clinical trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,101

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

9 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 20, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

October 23, 2019

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 11, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 11, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

May 7, 2025

Completed
Last Updated

June 8, 2026

Status Verified

May 1, 2026

Enrollment Period

4.5 years

First QC Date

August 13, 2019

Results QC Date

March 4, 2025

Last Update Submit

May 14, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Pain Intensity Subscale of Brief Pain Inventory

    Pain Intensity subscale of the Brief Pain Inventory uses a 0-10 numeric rating scale (0=no pain to 10=pain as bad as you can imagine) to measure four pain severity/intensity items: "worst" pain in the last 24 hours, "least" pain in the last 24 hours, "average" pain, and pain right "now". The pain intensity subscale is scored as a composite of the four pain items (mean intensity score).

    36 weeks

  • Change in Number of Problem Substances Measured by the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)

    Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was developed to detect and manage substance use and related problems. Substance use will be measured over the last 3 months using Version 3.1.After a screening question focusing on substances ever used, the ASSIST consists of 7 questions about use of and consequences of use of each of 11 classes of substances over the preceding three months (including nicotine, THC and medical THC). Scores are generated for each substance that are mapped to a three-point ordinal score of severity: "no need for treatment", "need for a brief intervention" and "need for an intensive intervention". The number of problem substances are defined as the number of substances above the "no intervention" threshold \*only participants who had a problem substance reported at baseline were analyzed for this outcome

    36 weeks

Secondary Outcomes (6)

  • Cost-Effectiveness Ratios (ICERs)

    36 weeks

  • Cost-Effectiveness Acceptability Curves (CEACs)

    36 weeks

  • Non-pharmacological Pain Service Utilization

    36 weeks

  • Pain Interference Subscale of Brief Pain Inventory

    36 weeks

  • Overall Health Measured by EQ-5D-5L

    36 weeks

  • +1 more secondary outcomes

Study Arms (2)

SBIRT-PM

EXPERIMENTAL

Screening, Brief Intervention and Referral to Treatment for Pain Management (SBIRT-PM) was developed to promote engagement in multi-modal non-pharmacological pain management among compensation-seeking Veterans with chronic pain. In SBIRT-PM, a clinician meets with the Veteran after the compensation examination to address the presenting MSD complaint. The clinician addresses Veterans' motivation for multi-modal pain care, and explains how pain can be managed using a variety of non-pharmacological pain management services. The clinician spells out how those services can be accessed at VA. Using permissive language about how pain is commonly self-medicated with substances, the clinician transitions to inquiries about use of prescription and non-prescription substances. The clinician then attempts to motivate Veterans to change their behavior if they are misusing substances. Thus, SBIRT-PM addresses the Veteran's presenting pain complaint first and nascent substance use subsequently.

Behavioral: SBIRT-PM

Usual Care

NO INTERVENTION

A Veteran who completes a Compensation examination ordinarily has no further treatment, referral or debriefing as part of the Compensation examination. Veterans will be advised that they should continue to pursue whatever counseling they need outside the study.

Interventions

SBIRT-PMBEHAVIORAL

SBIRT-PM involves an initial telephone-delivered session followed by up to three calls to Veterans in a 12-week period to support Veteran engagement in multi-modal non-pharmacological pain care and to motivate those who misuse substances to change this problematic behavior. SBIRT-PM also includes coordination between the SBIRT-PM clinicians and the PACT nurse case manager after the initial session to support these patient outcomes.

SBIRT-PM

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Post-9/11 Veteran applying for MSD-related compensation, as ascertained from filed claim,
  • Reports a score of ≥4 (threshold for moderately severe pain) on the BPI's Pain Severity subscale (average of four pain intensity items);
  • Availability of a landline or cellular telephone for SBIRT-PM.

You may not qualify if:

  • Reports inability to participate during the study enrollment call
  • Received three or more non-pharmacological pain treatment modalities within the last 12 weeks from VA.
  • Participating in another PMC3 study as evidenced by a research protocol alert for that study at the time the study invitation letter is mailed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (9)

Yale University

New Haven, Connecticut, 06520, United States

Location

VA Connecticut Healthcare System (VACHS)

West Haven, Connecticut, 06516, United States

Location

VA Maine Healthcare System

Augusta, Maine, 04330, United States

Location

Edith Nourse Rogers Memorial VA Hospital (VA Bedford)

Bedford, Massachusetts, 01730, United States

Location

VA Boston Healthcare System

Boston, Massachusetts, 02301, United States

Location

VA Central Western Massachusetts Healthcare System

Leeds, Massachusetts, 02053, United States

Location

Manchester VA Medical Center

Manchester, New Hampshire, 03104, United States

Location

Providence VA Medical Center

Providence, Rhode Island, 02908, United States

Location

White River Junction VA Hospital

White River Junction, Vermont, 05001, United States

Location

Related Publications (1)

  • Rosen MI, Gilstad-Hayden K, Lazar CM, Sellinger J, Mattocks K, Barnett PG, Brummett BR, Higgins DM, Holtzheimer P, Livingston NA, Ngo T, Reznik TE, Schimelman B, Semiatin AM, Solzhenitsyn C, Martino S. Motivational Interviewing Targeting Pain and Substance Use in Veterans Seeking Service-Connection Payments: A Multisite Randomized Clinical Trial. J Gen Intern Med. 2026 Feb 25. doi: 10.1007/s11606-025-10127-2. Online ahead of print.

MeSH Terms

Conditions

Substance-Related DisordersPain

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Marc Rosen, MD
Organization
Yale University

Study Officials

  • Marc Rosen, MD

    Yale University/ VA Connecticut Healthcare System

    PRINCIPAL INVESTIGATOR
  • Steve Martino, PhD

    Yale University/ VA Connecticut Healthcare System

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Research Assistants collect data from participant interviews at 12 and 36 weeks follow-up. They will be blind to randomization condition.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants receive either usual care or study intervention
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2019

First Posted

August 20, 2019

Study Start

October 23, 2019

Primary Completion

April 11, 2024

Study Completion

April 11, 2024

Last Updated

June 8, 2026

Results First Posted

May 7, 2025

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL
Access Criteria
Data are available upon reasonable request. Datasets containing individually identifiable data will only be shared with a written assurance from the recipient that (1) the information will only be used for research purposes and will not be used to identify any individual participant; (2) the information will be secured using appropriate computer technology; and (3) the data will be destroyed or returned after analyses are completed.

Locations